Amneal Pharmaceuticals Issues Voluntary Nationwide Recall of Magnesium Sulfate in Water for Injection, USP 4 G/100mL Due to a Product Mix-Up With Tranexamic Acid in 0.7% Sodium Chloride Injection, 10 Mg/mL
March 25, 2026
March 25, 2026
WASHINGTON, March 25 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following recall notice:
* * *
Amneal Pharmaceuticals LLC Issues Voluntary Nationwide Recall of Magnesium Sulfate in Water for Injection, USP 4 g/100mL (NDC 70121-1720-3) Due to a Product Mix-up with Tranexamic Acid in 0.7% Sodium Chloride Injection, 10 mg/mL
Summary
Company Announcement Date: March 24, 2026
FDA Publish . . .
* * *
Amneal Pharmaceuticals LLC Issues Voluntary Nationwide Recall of Magnesium Sulfate in Water for Injection, USP 4 g/100mL (NDC 70121-1720-3) Due to a Product Mix-up with Tranexamic Acid in 0.7% Sodium Chloride Injection, 10 mg/mL
Summary
Company Announcement Date: March 24, 2026
FDA Publish . . .
